McDermott, M. S. J., Conlon, N., Browne, B. C., Szabo, A., Synnott, N. C., O’Brien, N. A., . . . O’Donovan, N. (2019). HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells. Cancers (Basel).
Chicago Style citaatMcDermott, Martina S. J., Neil Conlon, Brigid C. Browne, Adam Szabo, Naoise C. Synnott, Neil A. O’Brien, Michael J. Duffy, John Crown, en Norma O’Donovan. "HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells." Cancers (Basel) 2019.
MLA citatieMcDermott, Martina S. J., et al. "HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells." Cancers (Basel) 2019.
Let op: Deze citaties zijn niet altijd 100% accuraat.